Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

Drugmakers are planning broad price adjustments in 2026, raising new questions about affordability, policy pressure, and what ...

Rep. Anna Paulina Luna (R-Fla.) is “hopeful” Congress will codify President Trump’s executive order on capping prescription ...

​In an announcement on November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) revealed the new Maximum Fair ...

While the president has repeatedly pulled back the curtain on Big Pharma, it hasn’t stopped the pharmaceutical industry from pursuing a creative approach to keeping Americans stuck with list prices ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

The cost of prescription drugs is soaring. A new report shows, even during the pandemic, consumers have had to pay three times more for some of their medicines. The latest RX Price Watch Report from ...